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Abstract
Spt5 is a conserved essential protein that represses or stimulates transcription elongation in vitro. Immunolocalization
studies on Drosophila polytene chromosomes suggest that Spt5 is associated with many loci throughout the genome.
However, little is known about the prevalence and identity of Spt5 target genes in vivo during development. Here, we
identify direct target genes of Spt5 using fogsk8 zebrafish mutant, which disrupts the foggy/spt5 gene. We identified that
fogsk8 and their wildtype siblings differentially express less than 5% of genes examined. These genes participate in diverse
biological processes from stress response to cell fate specification. Up-regulated genes exhibit shorter overall gene length
compared to all genes examined. Through chromatin immunoprecipitation in zebrafish embryos, we identified a subset of
developmentally critical genes that are bound by both Spt5 and RNA polymerase II. The protein occupancy patterns on
these genes are characteristic of both repressive and stimulatory elongation regulation. Together our findings establish Spt5
as a dual regulator of transcription elongation in vivo and identify a small but diverse set of target genes critically
dependent on Spt5 during development.
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Introduction
The production of functional mRNA involves multiple steps
that include transcription initiation, elongation, and termination.
The initiation step is thought to be the major regulatory point for
most genes in vivo, despite that promoter-proximal stalled RNA
polymerase II (RNAPII) has been detected at several loci including
hsp70 [1], HIVLTR [2], c-myc [3], and c-fos [4]. Recently, it has
been observed that promoters of many genes are poised for
activation, as assessed by chromatin status and RNAPII occupancy
in human Hela cells, mammalian embryonic stem cells, and
Drosophila embryos [5–9]. These observations suggest that
regulation at the level of transcription elongation may be more
prevalent than previously thought. However, the distinct role of
individual transcription elongation factors in critically regulating
elongation of target genes remains unclear.
In recent years, biochemical studies have identified over a dozen
proteins and a small nuclear RNA, which regulate RNAPII
elongation in vitro [10–17]. Among these molecules, Spt5, an
evolutionarily conserved protein, is the focus of this study. Spt5,
together with Spt4 and Spt6, was initially discovered by genetic
studies in Saccharomyces cerevisiae [18], and later found to be essential
for transcription via modulating chromatin structure [19,20]. A
search for factors that inhibit transcription elongation in the
presence of the nucleotide analog 5,6-dichloro-1-b-D-ribofurano-
sylbenzimidazole (DRB) led to the biochemical purification of Spt4
and Spt5 as a tight complex named DSIF (DRB Sensitivity
Inducing Factor), which has both repressive and stimulatory
activity on transcription elongation in vitro [21]. Spt5 has also been
identified independently as a protein required for HIV-1 Tat
trans-activation in fractionated extracts [22]. In addition, Spt5
interacts and modulates activity of factors implicated in mRNA
maturation and surveillance [23–25].
At the phenotypic level, the in vivo role of Spt5 in multi-cellular
organisms has been revealed through genetic analyses in C. elegans,
Drosophila, and zebrafish. Inactivation of Spt5 through RNAi in C.
elegans arrest embryonic development prior to gastrulation [26]. In
Drosophila, a hypomorphic mutation in spt5 displays defects in the
expression of segmental patterning genes [27]. At the molecular
level, Spt5 localization on polytene chromosomes and chromatin
immunoprecipitation studies reveal broad distribution of Spt5 at
sites of active transcription as well as at the un-induced heat shock
gene promoters [28–30]. In zebrafish, whereas a hypomorphic
mutation in spt5 (the fogm806 allele) displays distinct defects in
neuronal development [31], severe truncation (the fogsk8 allele) or
deletion (the fogs30 allele) of the gene product causes broad deficits
in embryonic development [32]. Together, these analyses establish
functional significance of Spt5 in vivo, implicate intricate regulatory
mechanisms that remain to be elucidated, and suggest that Spt5
may regulate a large number of target genes in vivo. Despite these
insights, only the heat shock protein-encoding hsp70 and HIV viral
genes, have been demonstrated to be regulated at the level of
transcription elongation by Spt5 in intact cells [29,33], whereas
induction of the immediate early gene c-fos appears to depend on
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the stimulatory activity of Spt5 [34]. Thus, an important question
remains: What other genes, if any, are critically dependent on Spt5
in vivo?
Here we report expression profiling of over 10,000 protein-
coding genes using ,24 hours post fertilization (hpf) zebrafish
embryos. Our results identified a surprisingly small fraction (,5%)
of genes that were differentially expressed between fogsk8 mutants
and their wildtype (WT) siblings. Pathway analyses revealed that
these differentially expressed genes are involved in diverse
biological pathways that range from stress response to cell fate
specification. A gene structure analysis showed that genes
upregulated in fogsk8 embryos had a significantly shorter length,
compared to the average gene length in zebrafish. Furthermore, in
vivo chromatin immunoprecipitation (ChIP) on selected set of
differentially expressed genes in 24 hpf WT embryos uncovered
Spt5 target genes: among the target genes repressed by Spt5
(including gadd45b, c-fos, hsp70, smoothened, and follistatin), RNAPII
occupancy was higher at the 59 than 39 end of these genes; among
the target genes activated by Spt5 (including lunatic fringe and
tropomyosin a), RNAPII occupancy was detected at both their 59 and
39 ends. ChIP analyses in fogsk8 mutant embryos identified gadd45b
that exhibited significantly increased RNAPII occupancy at the 39
end compared to that in WT embryos, whereas other target genes
unexpectedly showed reduced RNAPII occupancy at both 59 and
39 ends. This observation highlights the dynamic and complex
nature of elongation regulation in vivo. Taken together, our results
establish Spt5 as a dual regulator of transcription elongation in vivo
and reveal a small but diverse set of direct target genes.
Results
Spt5 protein is significantly reduced in 24 hpf fogsk8
mutant embryos
The foggy/spt5 transcript is broadly distributed throughout the
developing embryo [31,32]. To gain insights into the level and
distribution of Spt5 protein, an antibody directed against the C-
terminal end of the zebrafish Spt5 protein was generated. Double-
labeling with 8WG16, an antibody that recognizes RNAPII,
demonstrated prominent nuclear distribution of Spt5 (Fig. 1A–B).
The fogsk8 mutation (Fig. 1F–G) is predicted to yield a non-
functional zygotic gene product, and the maternal transcript is
undetectable after 10 hours post fertilization (hpf) [32]. However,
the status of the maternal protein was unclear. The sk8 mutant
phenotype is first visible around 19 hpf, suggesting the presence of
maternal Foggy protein at earlier stages of development.
Immunostaining (Fig. 1C–D) showed that maternal Spt5 protein
was significantly reduced in fogsk8 mutant embryos as compared to
WT siblings. Western blotting (Fig. 1E) detected two bands around
the predicted size of zebrafish Spt5 in WT embryos. Since Spt5 is
known to be phosphorylated [14,34–38] and methylated [39],
these bands may represent forms of Spt5 with different post-
translational modifications. Although the intensity of both bands
was reduced in the fogsk8 mutant, the faster migrating form
appeared more severely affected (Figure 1E). This result indicates
that fogsk8 mutant at 24 hpf exhibits a significant reduction but not
complete absence of Spt5 protein.
Expression profiling reveals a small number of
differentially expressed genes in 24 hpf fogsk8 embryos
To identify potential downstream target genes of Spt5, we
performed microarray analysis by hybridizing zebrafish Affymetrix
oligoarrays, which contain over 10,000 protein-coding genes, with
biotinylated cRNA probes from 24 hpf fogsk8 mutant and WT
sibling embryos. 75% of the probe sets displayed above-
background signal-to-noise ratio (as determined by microarray
absent-present calls), suggesting that a majority of genes on the
array have detectable expression at this stage. Interestingly
however, only 4.5% of the genes were differentially expressed
(absolute fold greater than 2, student t-test P,0.05) between fogsk8
and WT siblings. The 2-fold cutoff was used because an expression
change of less than 2 fold was often not validated by quantitative
PCR analysis (data not shown). Among the differentially expressed
genes, 97 (,1% of the total genes examined) were up-regulated
(ranging from +2- to +10-fold), and 358 (,3.5% of the total genes
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Figure 1. Spt5 protein is significantly decreased in fogsk8
embryos. (A–B) Whole mount immunofluorescence detection of
Spt5 and RNAPII in zebrafish embryos, showing the nuclear localization
pattern of Spt5 protein. (C–D) Whole mount immunofluorescence
detection of Spt5 in WT and fogsk8 embryos at 24 hpf, showing overall
decrease of Spt5 protein in fogsk8 embryos. Confocal images of lateral
views are shown, with the anterior to the left and dorsal up. (E) Western
blot of wild-type (WT) and fogsk8 embryonic extracts at 19 hpf and
24 hpf shows substantial decrease in maternal Spt5 protein in the
mutant. (F–G) Light microscopic view of WT and sk8 embryos at 24 hpf,
showing the gross morphological phenotype of the mutant embryos.
doi:10.1371/journal.pone.0003621.g001
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GO Name NumberChanged
Number
Measured Z Score
Permute
P GO Type Corresponding Genes
extracellular matrix structural constituent 5 7 8.03 0 function col1a1, col1a2, col1a3, col2a1a, matn4
tetrapyrrole metabolic process 4 6 6.90 0 process alas2, hmbs, hmox1, urod
Notch signaling pathway 6 15 6.20 0 process dla, dlb, dlc, dld, her4.1, notch3
ATP hydrolysis coupled proton transport 3 5 5.62 0.0015 process atp1a1a.4, atp1a2a, atp1a1b
calcium ion binding 23 167 5.26 0 function
cdh11, cdh15, cmlc1, dl(a,b,c,d), hsp90b1, lcp1, 
matn4, myl7, mylz(2,3), notch3, pvalb1, 
pvalb(2,5,8), tnnc
oxygen transporter activity 5 16 4.80 0.0005 function hbae1, hbae3, hbbe3, mb, vim
vascular endothelial growth factor receptor
activity 3 7 4.58 0.0005 function kdr, pdgfra, ttnl
Neurogenesis 14 113 4.56 0 Panther ascl1a, dld, lhx1b, rtn1b, tbr1, tlx3a, tnw, zgc:113283, zgc:64199
Dr_DNA_replication_Reactome 5 23 4.29 0.001 GenMAPP mcm2, mcm3, mcm4, mcm5, orc5l
porin activity 3 8 4.20 0.003 function aqp3, aqp8, zgc:85890
actin binding 6 27 4.09 0 function gsnl1, lcp1, sptb, svil, tmsb, tpma
Muscle development 5 30 3.50 0.004 Panther boc, im:6899248, myl7, pvalb8, ttnl
anatomical structure morphogenesis 17 159 3.32 0 process
atoh1a, atp1a1a.2, atp1a2a, boc, ccnd1, cx43, 
dld, gap43, igfbp1, kdr, lbr, notch3, oep, plasticin,
ptf1a, sox9b, tnc
somitogenesis 5 27 3.21 0.0025 process dlc, dld, her4.1, myhz2, oep
cytoskeleton organization and biogenesis 8 60 2.95 0.002 process epb41, prox1, sptb, svil, tmsb, tuba2, tubb5, zgc:112335
cell migration 6 53 2.10 0.018 process boc, lbr, nrarpa, oep, supt5h, tnc
protein tyrosine phosphatase activity 4 31 2.01 0.041 function ptprn2, ptprn, ptpn6, zgc:63553
viral envelope 3 4 13.25 0 component zgc:114014, zp2.2, zp2.4, zp3.2
response to cadmium ion 3 8 9.22 0 process gadd45b, hsp70, jun
pattern specification process 5 105 3.27 0.0035 process atp1a1a.1, fst, gadd45b, gadd45bl, smo
sequence-specific DNA binding 13 288 5.14 0 function bapx1, fos, foxd5, hox(b6a, b6b, b10a, c5a, 6a, d11a, d13a), jun, nkx2.7, six4.1
G-protein mediated signaling 3 79 3.28 0.044 Panther opn1sw2, smo, tpbgl
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Figure 2. Gene expression profiling reveals that the expression of a small percentage of genes is affected in fogsk8 mutant embryos.
(A) HOPACH cluster diagram of the microarray data are shown for individual replicates compared with the mean for 24 hpf embryos. 615 probe sets
with fold change .2 and t test P-value ,0.05 are displayed along with Gene Ontology terms and pathways over-represented as determined by a
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examined) were down-regulated (from 22- to 2300-fold) in fogsk8
embryos (Fig. 2A). Many of the differentially expressed genes have
previously been shown to display dynamic spatial and temporal
expression patterns [40]. Four genes (gch, pvalb, hoxb6, dlx2) were
validated through whole mount in situ analysis (Supplemental Fig.
S1) and 28 other genes were further validated through quantitative
RT-PCR analysis (Supplemental Tables S1 and S2).
To identify biological pathways that might be regulated by Spt5,
we employed GenMAPP [41] and associated tools [42] (http://
www.genmapp.org/go_elite) to analyze pathway and gene ontol-
ogy over-representation in our differentially expressed gene
dataset. This analysis found that genes induced by environmental
or cellular stress (such as gadd45b and hsp70) or encoding certain
transcription factors (such as foxd5 and fos) were upregulated,
whereas genes that are constituents of the extracellular matrix (e.g.
collagen) and sodium/potassium ion transporters (e.g. atp1a1a) were
down-regulated in fogsk8 embryos (Fig. 2A). The expression of
genes previously suggested to be regulated at the level of
elongation [10], including hsp70, fos, globin, tubulin, and opsin, were
found altered in fogsk8 embryos. Moreover, the expression of
multiple genes in the cell cycle pathway was reduced in fogsk8
embryos (Fig. 2B). In contrast, genes from major developmental
pathways (e.g. fibroblast growth factor, wingless), although present
on the array, were largely unaffected in fogsk8 embryos (Supple-
mentary Table S3). In addition, RNA processing genes and
protein biosynthesis genes (ribosome constituents) were under-
represented in our differentially expressed gene dataset (data not
shown). It is worth pointing out that many differentially expressed
were novel, and were thus not assignable to specific GenMAPP
pathways. Taken together, these results indicate that the lack of
zygotic Spt5 protein only affects the expression of a small
percentage of genes at 24 hpf, and these genes are involved in a
number of distinct biological pathways.
Genes that are upregulated in fogsk8 embryos are shorter
in gene length compared to all genes examined
Little is known as to what signatures may subject a gene to Spt5
regulation. To determine if differentially expressed genes have
common features in gene structures, we performed bioinformatics
analysis on these gene sets. To assess the extent and overall
likelihood of a difference between the length of fogsk8 –dependent
genes and that of all other genes in the array, probe sets from the
microarray were linked to gene structure data from the Ensembl
database, the mean of different gene features (e.g., genomic length)
was computed, and fold change and P values were calculated via a
permutation based analysis (Fig. 3A).
Using this method, we found that genes upregulated in fogsk8
embryos had on average ,2.39 fold decrease in overall gene
length and ,1.69 fold decrease in intron length, as compared to
all gene-linked probe sets on the array (P,0.05) (Fig. 3B). These
differences were unlikely to occur due to chance, because a fold
change larger than or equal to the gene length difference (2.39
fold) was not observed in 10,000 random permutations of all
microarray probe sets, and that larger than or equal to the intron
length difference (1.69 fold) only occurred twice over 10,000
random permutations (P=0.0002), hence emphasizing the
unlikelihood of such events occurring at random. Although this
analysis also showed a significant increase in exon length for
upregulated genes, the difference was relatively small (1.26 fold).
None of the gene structure data differed between downregulated
genes and all other genes on the array (Fig. 3B). Taken together,
this analysis suggests that genes repressed by Spt5 tend to be
shorter in length.
In vivo chromatin immunoprecipitation (ChIP) reveals
Spt5 occupancy patterns on differentially expressed
genes in 24 hpf WT embryos
As microarray experiments measure the steady-state levels of
mRNA and Spt5 is involved in many aspects of mRNA stability by
virtue of its association with many components of the transcriptional
machinery , many of the genes differentially expressed in fogsk8
mutants might represent mRNA processing targets of Spt5. In order
to better identify genes that are regulated at the elongation level at
24 hpf, we performed chromatin immunoprecipitation (ChIP)
assays using antibodies against RNAPII and Foggy.
Based on the current model of regulation at the level of
transcription elongation [16,17], the following patterns of Spt5
and RNAPII occupancy are expected on their target genes (Fig. 4):
A) Spt5 target genes that are in a state of productive transcription
elongation shall display Spt5 and RNAPII occupancy at both 59 and
39 ends of their chromatin. B) Spt5 target genes that are repressed by
a promoter-proximal transcription elongation block shall have
minimal Spt5 and RNAPII occupancy at 39 end but significantly
more Spt5 and RNAPII occupancy at 59 end. C) Genes that are not
Spt5 targets or are transcriptionally inactive shall lack detectable
Spt5 or RNAPII respectively throughout their chromatin.
Based on the significance of expression fold changes, constraints
on availability of reliable genomic structure (exon/intron)
information, and known gene functionality, 11 upregulated genes,
7 downregulated genes, and 3 control genes were selected for
ChIP analysis (Table 1 and Supplementary Table S4) in 24 hpf
WT embryos. Among the 11 upregulated genes, 8 (gadd45b, fos,
hsp70, smo, atf3, fst, tpbgl, foxd5) showed high Spt5 occupancy at 59
end but little at 39 end, whereas the remaining three genes did not
show significant Spt5 occupancy on either end (Fig. 5A and
Table 1). Among the 7 downregulated genes, 3 (lfng, tpma, a2bp1-
like) showed significant Spt5 occupancy at both 59 and 39 ends,
whereas the remaining 4 genes did not (Fig. 5B and Table 1).
Genes that showed significant Spt5 occupancy are likely to be
targets of Spt5, whereas those that did not have significant Spt5
occupancy were either transcriptionally inactive or not directly
regulated by Spt5. Two (beta-actin 1 and cyclin E) of the three
control genes showed significant Spt5 occupancy (Fig. 5C and
Table 1), whose expression was largely unaltered in 24 hpf fogsk8
embryos, suggesting that these transcripts might be regulated by
additional elongation factors.
ChIP analysis using the 8WG16 antibody in 24 hpf WT
embryos reveals RNAPII distribution patterns on the
differentially expressed genes
We next examined RNAPII distribution in 24 hpf WT embryos
to determine the transcriptional status of the genes. The 8WG16
antibody was used in our experiments, as it has been successfully
Fisher’s exact test permutation based P-value. The intensity of down-regulation (green) and up-regulation (red) reflects the magnitude of fold
change. Representative genes within the GO categories are shown in the last column. Genes subjected to further analyses in this study are
represented in blue color in the last column. (B) G1 to S Cell Cycle pathway is shown as an example of GenMAPP pathway analysis. The pathway map
shows genes that are regulated as a group (e.g. mcm genes) and genes that are not differentially expressed in fogsk8 embryos but are present on the
array (grey color).
doi:10.1371/journal.pone.0003621.g002
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Figure 3. Permutation analysis uncovers a significant shorter length of those genes that are up-regulated in fogsk8 mutant embryos.
(A) Algorithm design for assessing global changes in overall gene length. Unique Ensembl genes linked to probesets were obtained from the
Affymetrix website and BioMart, and genomic gene, exon and intron length were also obtained from BioMart and summarized for up-, down-
regulated and all array probesets (AAPs). Folds relative to AAPs linked genes were calculated as well as permutation based p-values by randomly
selecting input probeset lists of the same size as the regulated sets from AAPs, over 10,000 iterations. (B) Table summarizing the permutation based
analysis of the structural features of genes differentially expressed in fogsk8 embryos. Up-regulated genes have significantly shorter gene length,
shorter intron length and longer exon length than other genes on the array. Down-regulated genes do not show significantly different gene structure
requirements compared to other genes.
doi:10.1371/journal.pone.0003621.g003
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used to recognize RNAPII occupancy on the chromatin at both
the 59 and 39 ends of genes in other species [43]. In general, the
RNAPII occupancy pattern correlated well with that of Spt5.
Among those that were upregulated in the fogsk8 mutant embryo
and also displayed significant Spt5 occupancy (indicating that their
expression is repressed by Spt5), more RNAPII was detected at 59
than 39 end (Fig. 6A, 6D, and Table 1). This finding is consistent
with the idea that the genes repressed by Spt5 are in a poised state
of transcription. Among those that were downregulated in the
fogsk8 mutant embryo and also displayed significant Spt5
occupancy, significant occupancy of RNAPII was also detected
at both 59 and 39 ends (Fig. 6B, 6D, and Table 1), indicating that
these genes require the stimulatory activity of Spt5 for productive
transcription in 24 hpf WT embryos. The genes that exhibited
little Spt5 occupancy also showed little RNAPII occupancy,
confirming that these genes are not transcriptionally active in
24 hpf WT embryos. Taken together, our results identify gadd45b,
fos, hsp70, tpbgl, smo, atf3, fst, and foxd5 as target genes that are
repressed by Spt5 at the elongation step, and lfng, tpma, and a2bp1-
like as target genes that are activated by Spt5 at the elongation
step. Though genes such as fos and hsp70 have been known to be
regulated by elongation, our results identify multiple critical
developmental regulators such as smo (regulating Hedgehog
signaling) [44], fst (regulating Transforming Growth Factor beta
signaling) [45], and lfng (regulating Notch signaling) [46] as novel
elongation targets of Spt5.
Analysis of RNAPII occupancy on putative Spt5 target
genes in 24 hpf fogsk8 embryos
Based on the above results and current model of transcription
elongation, one might expect, in the fogsk8 embryos, an increased
occupancy of RNAPII at 39 end of the genes whose transcription
elongation is repressed by Spt5 in WT embryos. Alternatively,
depletion of Spt5 may lead to a decreased association of RNAPII
with the 59 end of genes, due to a reduced level of promoter-
proximal pausing, as has been observed in the case of NELF
depletion [8]. To test these predictions, in vivo ChIP was carried
out using RNAPII antibody in 24 hpf fogsk8 embryos. Due to
limited availability of fogsk8 embryos, we focused on five genes,
hsp70, fos, gadd45b, fst, and smo. The patterns of RNAPII
occupancy in 24 hpf fogsk8 embryos were shown in Fig. 7. For
most genes tested, we observed significantly decreased RNAPII
occupancy at 59 end and no increase of occupancy at 39 end, in
comparison to that in WT embryos, consistent with the second
prediction. One gene, gadd45b, however, fitted with the first
prediction: RNAPII occupancy at its 59 end was similar between
WT and fogsk8 mutant embryos, but RNAPII occupancy at its 39
end was significantly increased in fogsk8 embryos as compared to
WT (Fig. 7). Reasons behind such differential patterns of RNAPII
occupancy at different target genes were not clear (see Discussion).
Taken together, our in vivo expression profiling and ChIP analyses
indicate that Spt5 exerts dual activity in regulating mRNA
expression and RNAPII occupancy in vivo and in a gene-specific
manner.
gadd45b mRNA is globally increased leading to increased
protein products in fogsk8 embryos
The one gene that did show increased RNAPII occupancy in
the fogsk8 mutant, gadd45b, is regulated by multiple important
cellular signaling pathways including NF-kB and JNK [47] and is
involved in zebrafish somitogenesis [48]. To probe the significance
of Spt5 regulation of this gene, we asked whether and where in the
fogsk8 embryos the de-repression of gadd45b results in overall
mRNA increase, through whole-mount in situ hybridization. In
16 hpf WT embryos, gadd45b was strongly expressed in the
developing somites, and such expression was largely normal in the
fogsk8 mutant (Fig. 8A–B). In 24 hpf WT embryos, gadd45b
expression was detected in cells of pronephric ducts and weakly
in posterior paraxial mesoderm and minimally elsewhere (Fig. 8C,
8E, 8G), revealing the dynamic nature of gadd45b expression in
development. In 24 hpf fogsk8 embryos, a global increase of gadd45b
RNA (Fig. 8D, 8F, 8H), and protein (Fig. 8I) was detected, thus
demonstrating the significance of Spt5 regulation of this gene.
Discussion
Spt5 has a demonstrated dual activity in regulating transcription
elongation in vitro [21], and may regulate a large number of genes
in vivo [28,29,49]. However, the prevalence and identity of genes
whose expression is critically dependent on Spt5 are poorly
defined in any in vivo system. In this study, we have carried out
expression profiling of over 10,000 genes using a zebrafish zygotic
null mutant, fogsk8. Maternally deposited foggy/spt5 gene products
have sustained fogsk8 embryos to a developmental stage when
sufficient amount of tissues are experimentally available and foggy/
spt5 gene products become significantly depleted. Our results show
that a surprisingly small fraction of genes (,5%) are differentially
expressed between WT and fogsk8 embryos at 24 hpf. In vivo ChIP
analyses with both Spt5 and RNAPII antibodies on a select set of
genes further identify targets that are regulated either by the
repressive or by the stimulatory activity of Spt5 at the level of
transcription elongation. The observation that Spt5 associates with
control genes confirm that Spt5 occupancy does not equate to
functional necessity. Moreover, RNAPII occupancy patterns
observed in fogsk8 embryos emphasize the dynamic and complex
nature of transcription regulation by Spt5 in a gene-specific
manner in vivo.
The prevalence of target genes that require Spt5
regulation in vertebrate development
Previous immunolocalization studies using Drosophila polytene
chromosomes show that non-productively elongating RNAPII,
together with Spt5, labels many chromosomal sites [28,29].
Recent genome-wide analyses also find significant RNAPII
occupancy at the 59 end of many genes, whether or not their
transcripts can be detected [5–7]. These studies imply that most, if
not all, genes may be dependent on Spt5 for transcription
regulation. In contrast to this view, our survey of over 10,000
genes at one developmental stage (24 hpf) reveals less than 5% of
differentially expressed genes in fogsk8 embryos. Several possibilities
may explain why such a small fraction of genes show altered
expression in fogsk8 embryos: First, as localization does not always
reflect functional dependence, it is possible that, although a much
3’’
1 2 3 4
5’
3’
1 2 3 4
5’
3’
1 2 3 4
5’
A. Spt5 or RNAPII occupancy at both 5’ and 3’:
Active transcription
B. Higher Spt5 or RNAPII occupancy at 5’ end:
Poised transcription
C. Little Spt5 or RNAPII occupancy at either end:
Little transcription
Figure 4. Schemata showing predicted transcriptional status
based on Spt5 and RNAPII occupancy.
doi:10.1371/journal.pone.0003621.g004
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larger number of genes are bound by Spt5, only a fraction of them
are critically dependent on its activity. Indeed, our ChIP analyses
have found that Spt5 are associated with two genes whose
expression is largely unchanged in fogsk8 embryos. Second, despite
significant reduction of Spt5 protein level in fogsk8 embryos, some
maternal proteins still remain, which could mask the identification
of those genes whose expression is not particularly sensitive to Spt5
protein reduction. Although removal of maternal Spt5 will allow
the test of this hypothesis, it may potentially lead to early death of
embryos, rendering the experiments impossible to carry out.
Third, since this expression profiling experiment cannot distin-
guish the relative contribution of maternal versus zygotic mRNA
to the steady state mRNA levels, it remains possible that maternal
mRNAs that are not yet degraded by 24 hpf could mask changes
of Spt5-dependent zygotic gene expression. Finally, since only one
developmental stage is examined in this study, it remains possible
that a different set of genes and/or a much larger number of them
may show altered expression in the mutant at other developmental
stages. Interestingly, when we analyzed the expression of 21
candidate target genes in a hypomorphic mutation (the fogm806
allele) at 48 hpf, 15 of the genes tested were unchanged while four
(fos, ndrg1, atp1a1a.4 and pvalb) showed similar trend as in fogsk8
mutant (Supplemental Table S5). This observation suggests that
the fogm806 allele is likely to affect even smaller number of genes.
Taken together, we suggest that, at the late segmentation stage of
zebrafish development, only a small fraction of genes is critically
dependent on Spt5 for transcription regulation, even though a
large number of genes may recruit Spt5 to their chromatin.
Target genes that are positively or negatively regulated
by Spt5
In addition to previously known categories of inducible genes,
our pathway analysis revealed that Spt5 target genes belong to
diverse biological pathways and functions. Further studies are
required to bridge the gap between the known function of the
genes to the mechanism of their gene regulation at the elongation
level, particularly to developmentally regulated genes. Our
bioinformatics analyses reveal that genes repressed by Spt5 are
significantly shorter in gene length. Two possibilities, not mutually
exclusive, may account for this observation: First, as one distinct
advantage of regulating transcription elongation is to allow rapid
gene induction in response to extrinsic signals, genes that are
regulated in this manner may have been selected during evolution
to have shorter length, in order to further accommodate the need
for accelerated transcription. Interestingly, genes with shorter
introns and overall shorter gene length are hallmarks of immediate
early (IE) genes. Since only three of the genes up-regulated in the
fogsk8 appear to be well- characterized IE genes (gadd45b, fos and
jun), further studies are required to determine if other genes
represented in this category also function as IE genes. Second,
since the severe depletion of Spt5 in fogsk8 embryos lead to deficits
of not only the repressive but also the stimulatory activity, it is
Figure 5. In vivo ChIP analysis using Spt5 antibody on
differentially expressed genes reveals putative target genes
directly bound by Spt5. (A–C) Spt5 occupancy on upregulated,
downregulated, and control genes. Y- axis values in the graphs
represent fold Foggy occupancy over fold pre-immune serum
occupancy levels. Arbitrary cutoff for detectable Foggy fold occupancy
over control serum is set at 5. Thick black bars highlight the genes that
display significant Spt5 occupancy at either 59 or 39 end of the
chromatin. The results shown are the average of at least three
independent replicates. Error bars are SEM values. Note that the scales
are different for each of the graphs.
doi:10.1371/journal.pone.0003621.g005
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possible that the genes with longer length are not up-regulated in
fogsk8 embryos because of their dependency on both the repressive
as well as the stimulatory activity of Spt5.
Our expression profiling together with in vivo ChIP analyses at
one developmental stage have identified two non-overlapping sets
of target genes: those that are negatively regulated by Spt5 and
those that are positively regulated by Spt5. Are there indeed two
distinct populations of genes that differentially require Spt5
activity in vivo? We suggest not. First, this study found that hsp70
belongs to the group that is negatively regulated by Spt5. Under
heat stimulus, however, it has been previously shown that hsp70
induction also depends on Spt5 [32]. Thus, one gene may require
both the repressive and the stimulatory activity of Spt5, depending
on developmental states or surrounding environmental signals.
Spt5 is shown to be phosphorylated by the positive elongation
kinase P-TEFb [14,34,36–38], and such phosphorylation is
proposed to act as a switch that converts Spt5 from a repressor
to an activator [34]. Although such model remains to be tested in
vivo, it supports the idea that Spt5 and transcription elongation are
dynamically regulated in vivo, and same set of genes may be
regulated by the repressive and stimulatory activity of foggy/Stp5,
depending on the in vivo states.
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Dynamics and complexity of regulated transcription
elongation in vivo
Our ChIP analyses in fogsk8 embryos reveal decreased RNAPII
occupancy along the chromatin of four genes (fos, hsp70, fst, and
smo) among total five genes tested. Since the transcripts of these
genes are increased in fogsk8 embryos at 24 hpf, together with the
demonstrated RNAPII and Spt5 occupancy on these genes in WT
embryos, one possible explanation is that increased 39 RNAPII
occupancy may have occurred at an earlier developmental stage,
coinciding with the onset of transcript increase from these genes.
Because of Spt5 depletion, promoter-proximal association of
RNAPII was reduced subsequently in fogsk8 mutant embryos,
resulting in observed decrease of RNAPII occupancy at 24 hpf.
Indeed, it has been shown in yeast that Spt4-5 complex is
important for stabilizing RNAPII on the chromatin template
under normal and DNA-damage inducing conditions [50]. Similar
reduction of promoter-proximal associated RNAPII has also been
observed after NELF knockdown in Drosophila [8].
Among all the up-regulated genes subjected to ChIP analysis,
gadd45b showed increased RNAPII occupancy at the 39 end in the
fogsk8 mutant embryos. It also exhibited highest Spt5 occupancy at
the 59 end in WT (Figure 5A). In addition, the onset of gadd45b
mRNA increase in fogsk8 embryos may be rather close to 24 hpf,
since no increase in gadd45b mRNA was detected in 16 hpf fogsk8
embryos. These observations may explain why gadd45b displays
increased RNAPII occupancy patterns in fogsk8 embryos. The
significantly up-regulated Gadd45b protein levels suggest that the
produced gadd45b transcripts can be translated in vivo. In zebrafish,
overexpression of gadd45b by mRNA injection at the 1-cell stage
leads to somite segmentation defect and a down-regulation of myoD
[48]. Since gadd45b was not misexpressed in fogsk8 embryos until
late segmentation stages, fogsk8 embryos do not show obvious
segmentation defects and no reduction in myoD transcript levels
was observed in our expression profiling analysis. Thus, under-
standing the contribution of overexpressed gadd45b or any other
target genes to the fogsk8 mutant phenotype would require a precise
determination of temporal profiles of their expression in the fogsk8
mutant, followed by conditional knockdown or overexpression of
these target genes with temporal control.
How might the control of gadd45b expression by Spt5 fit into the
known regulation of gadd45b? Gadd45b is regulated by NF-kappaB
[51] and TGF-beta [52] in mammalian cell cultures, though its in
vivo regulation is poorly understood. Future studies are required to
elucidate any potential interaction between Spt5 and the NF-kB
and/or TGF-beta pathway members to understand the interplay
between DNA binding transcription factors and elongation
regulation of gadd45b. It has been previously suggested that gadd45
falls into the category of ‘preset’ genes whose upregulation is
independent of changes in chromatin structure (by binding of
transcription factors), or synthesis of new transcription factors, or
stimuli-induced DNA-protein interactions [53]. Hence, it is
tempting to speculate that the elongation control of gadd45b by
Foggy/Spt5 is the switch that regulates these ‘preset’ genes.
Transcription elongation control of such ‘preset’ genes might be
crucial to integrate signals from multiple pathways (gadd45b
controlled by NF-kB and TGF-b) to coordinate regulation of
important signaling pathways that ultimately determine cell fate
and survival.
Taken together, our findings provide the first comprehensive
view of in vivo target genes whose transcription is critically
dependent on Spt5 both positively and negatively during
vertebrate development. Further studies are required to elucidate
gadd45b fos hsp70 fst smo
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the complexities of elongation regulation through Spt5 in vivo, as
well as to determine the significance of such regulation on
individual target genes and their associated pathways.
Materials and Methods
Zebrafish strains and husbandry
Wild-type AB and fogsk8 embryos were obtained through natural
spawning and were maintained and staged according to
established procedures [54]. The use of zebrafish was approved
by UCSF ethics committee.
Total RNA isolation and quantitative RT-PCR
Equal number of embryos (WT siblings vs. fogsk8 mutants) at
24 hpf was dechorionated manually or by Pronase K treatment.
Trizol (Invitrogen) was used to extract total RNA that was DNase-
treated (Qiagen) to minimize contamination by genomic DNA
during qRT-PCR. To obtain cDNA, total RNA was reverse-
transcribed using oligodT and Superscript (Invitrogen). Equal
amount of cDNA was used in SybrGreen qPCR mastermix system
(Applied Biosystems) with appropriate primers (Supplemental
Table S2). All plates contained at least two-well duplicates for
each primer and cDNA condition. Cycle values were averaged
between the duplicates and normalized to control primer values.
WT fold values were compared to fogsk8 mutant fold values and
expressed as fold upregulated or downregulated in fogsk8 embryos.
At least two independent replicates were performed for each
primer set.
Microarray Data Analysis
Microarray hybridization was performed at the NINDS
microarray consortium using zebrafish Affymetrix oligonucleotide
arrays. Three independent replicates for each sample were
performed. Gene intensity values for the Affymetrix Zebrafish
Genome Array CEL files were obtained using the GC-RMA
package from Bioconductor [55]. To identify genes with relative
changes in steady-state mRNA levels between WT and fogsk8
mutants, a fold change was calculated from these log2 intensity
values along with a student t test p value. Genes with 2 fold change
in expression and p,0.05 were clustered using the program
HOPACH (hierarchical ordered partitioning and collapsing
hybrid), with uncentered correlation distance [56,57]. Associations
with Gene Ontology, GenMAPP [58] and PANTHER [59]path-
ways were obtained using MAPPFinder 2.0 [42], a part of the
GenMAPP 2.1 [41] application package and further filtered and
annotated using the program GO-Elite (http://www.genmapp.org/
go_elite/go_elite.html). The raw image and processed expression of
our microarray dataset is posted at NCBI’s Gene Expression
Omnibus database (GSE12826). To determine relative differences
in gene length parameters, a custom python script was written that
links microarray probe set data to gene structural information
from the Ensembl database (PMID: 17148474) obtained through
BioMart [60]. Probe set annotations to Ensembl genes obtained
from BioMart were augmented with those directly from
Affymetrix (http://www.affymetrix.com). In this script, fold
changes were calculated by comparing the mean length of distinct
gene features (genomic, exon and intron lengths/number) or gene
expression between upregulated or downregulated Ensembl-linked
genes compared to all genes on the microarray. For each
parameter, a permutation p value was calculated by randomizing
the selection of input probe sets 10,000 times and re-calculating
and storing the mean fold changes for both up and down regulated
sets to determine the probability that the original fold occurs by
chance alone.
Chromatin Immunoprecipitation (ChIP) Assay
WT embryos at 24 hpf were dechorionated by Pronase
treatment and washed thoroughly. Embryos were fixed in 1.5%
Figure 8. Global increase of gadd45 mRNA and increased
Gadd45b protein in fogsk8 mutant embryos. (A–H) Whole-mount
in situ hybridization using the gadd45b antisense probe in WT and
fogsk8 embryos at 16 hpf and 24 hpf. gadd45b expression is not
increased at 16 hpf but shows widespread increase at 24 hpf in fogsk8
embryos. (I) Western blot analysis of WT and fogsk8 embryo extracts with
commercially available anti-Gadd45b antibody and anti-Actin antibody
shows significant increase of Gadd45b protein in fogsk8 embryos at
24 hpf.
doi:10.1371/journal.pone.0003621.g008
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formaldehyde for 20 minutes and then homogenized 25 times in
56 extraction buffer with protease inhibitors on ice. Sonication
was carried out with Branson sonifier 250 on an ice bath for 10
times, 10 seconds each with 20 second breaks. Sonicated samples
were then centrifuged at 14k rpm at 4uC for 30 minutes to
separate the pellet from the supernatant. The supernatant was
immunoprecipitated with the following antibodies: 8WG16 Ab-
1:40 (Covance Research Products), Anti-Spt5 antibody 1:10, and
control sera -Normal mouse serum-1:100 (Sigma) and Rabbit pre-
immune serum (1:10) for 2–4 hours in the cold room. Protein A
Sepharose (Sigma) beads were added to the samples and left on
overnight. The next day, extensive washing with different buffers
were performed before eluting the beads at 65uC for 20 minutes.
Proteinase K and RNase were added to the eluates and reverse-
crosslinked overnight at 65uC. Phenol/chloroform extraction
followed by ethanol precipitation was performed. The immuno-
precipitated DNA was immediately used for qPCRs with
appropriate primers (Supplemental Table S4). All cycle values
were first normalized to input values before comparing control
samples to immunoprecipitated samples. These values were
represented as fold occupancy over control values. The procedure
was performed similarly for fogsk8 embryos.
Whole mount in situ hybridization and
immunocytochemistry
Whole-mount in situ hybridization was performed as previously
described [61]. Plasmid containing pBS-gadd45b was obtained from
ZIRC, and antisense probe was made using T7 RNA polymerase
(Ambion). Whole-mount immunocytochemistry was performed
similarly with appropriate antibodies (8WG16 ab- 1:100; Anti-
zfSpt5 antibody – 1:5000; CTD4H8 –AF488 – 1:2500) and
fluorescent secondary antibodies. Images were taken with Zeiss
epi-fluorescent and confocal microscopes.
Western Blot
Dechorionated embryos were fixed in 1.5% formaldehyde for
20 minutes and homogenized before addition of 26SDS loading
buffer. Equal amounts of the extracts were loaded on to the wells
of the gel. Primary antibodies (Anti-Foggy antibody-1:6000; Anti-
Actin antibody – 1:2000; Anti-Gadd45b antibody – 1:100) and
secondary antibody conjugated to horse-radish peroxidase (HRP)
were used. The ECL kit (Amersham) was used to visualize the
protein bands transferred from the blot to film.
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